Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Randomized Comparative Study to Evaluate the Use of Remifentanil as a Sole Agent or in Combination With Midazolam Versus Fentanyl/Midazolam During Sedation for Colonoscopy

NCT03037892 is registered in ClinicalTrials.gov with King Hamad University Hospital, Bahrain as lead sponsor.

NCT NCT03037892
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03037892 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Randomized Comparative Study to Evaluate the Use of Remifentanil as a Sole Agent or in Combination With Midazolam Versus Fentanyl/Midazolam During Sedation for Colonoscopy
Lead sponsor
King Hamad University Hospital, Bahrain
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2015
Completion date
May 31, 2018
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colonoscopy